Furthermore, to verify the contribution of CD4+ and CD8+ T cells to the anti‐tumour immune response post radiotherapy in the context of TTN, we selectively depleted these cell populations individually or simultaneously using corresponding antibodies in an MC38 cell line implanted model in C57BL/6 mice and analyzed their impact on tumour growth (Figure 7D). The gene discussed is CD8A; the disease is neoplasm.